Cite
HARVARD Citation
Lotan, Y. et al. (2021). Decision Analysis Model Comparing Cost of IsoPSA™ vs Repeat Biopsy for Detection of Clinically Significant Prostate Cancer in Men with Previous Negative Findings on Biopsy. Urology practice. 8 (1), pp. 40-46. [Online].